Boots No7 has launched its new Future Renew skincare range, claiming it represents a 'world-first breakthrough' in anti-ageing research. The products, which include creams and serums, are based on 15 years of collaboration with the University of Manchester and were presented at the American Academy of Dermatologists' annual congress.
The key ingredients are two 'super peptides' designed to boost the skin's natural repair process. Dr Mike Bell, head of science research for No7, said the products help the skin 'help itself' by increasing levels of fibrillin proteins that improve elasticity. However, the initial study on eight volunteers only showed increased protein levels, not visible wrinkle reduction.
A clinical trial with 44 women compared the Future Renew formulation to a simple SPF cream on the other half of the face. Experts graded the results using the Griffiths Wrinkle Scale, and Bell claimed the serum produced 'five years of wrinkle-reversal'. However, independent experts note that the trial tested the full formulation, making it difficult to isolate the peptides' effects.
Dr Claire Higgins of Imperial College London described the research as 'more of an incremental finding' than a revolution, praising the computational approach but noting that skin ageing involves other factors like DNA damage. Bell also downplayed suggestions that the products could treat scars or burns, stating they are 'very clearly in the cosmetic space'.
